title: Complete regression of melanoma skin metastases after electrochemotherapy plus ipilimumab treatment: an unusual clinical presentation.
authors.affiliation: Department of Medical Sciences, University of Turin v. Cherasco 23, 10126, Torino, Italy.
authors.forename: Matteo
authors.initials: M
authors.lastname: Brizio
authors.affiliation: Department of Medical Sciences, University of Turin v. Cherasco 23, 10126, Torino, Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: Fava
authors.affiliation: Department of Medical Sciences, University of Turin v. Cherasco 23, 10126, Torino, Italy.
authors.forename: Chiara
authors.initials: C
authors.lastname: Astrua
authors.affiliation: Department of Medical Sciences, University of Turin v. Cherasco 23, 10126, Torino, Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Cavaliere
authors.affiliation: Department of Medical Sciences, University of Turin v. Cherasco 23, 10126, Torino, Italy.
authors.forename: Paola
authors.initials: P
authors.lastname: Savoia
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D053672:Electrochemotherapy; D006801:Humans; D000074324:Ipilimumab; D007866:Leg / Q000473:pathology; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D012074:Remission Induction; D012878:Skin Neoplasms / Q000473:pathology / Q000556:secondary / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000074324:Ipilimumab